Tacrolimus therapy in adult-onset steroid-resistant nephrotic syndrome due to a focal segmental glomerulosclerosis single-center experience

Nephrology Dialysis Transplantation

Volumn 29, Issue 10, 2014, Pages 1918-1924

  Ramachandran, Raja ^a   Kumar, Vivek ^a   Rathi, Manish ^a   Nada, Ritambhra ^a   Jha, Vivekanand ^a   Gupta, Krishan Lal ^a   Sakhuja, Vinay ^a   Kohli, Harbir Singh ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

eGFR; FSGS; TAC

Indexed keywords

LIPID; PREDNISOLONE; TACROLIMUS; CREATININE; IMMUNOSUPPRESSIVE AGENT; STEROID;

ADULT; ARTICLE; BACTERIAL PNEUMONIA; CANDIDIASIS; CLINICAL ARTICLE; DIABETES MELLITUS; DIARRHEA; DRUG DOSE REDUCTION; DRUG RESPONSE; DRUG WITHDRAWAL; FEMALE; FOCAL GLOMERULOSCLEROSIS; GINGIVA HYPERPLASIA; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INFECTION; LIVER DYSFUNCTION; MALE; MINIMUM PLASMA CONCENTRATION; NAUSEA AND VOMITING; NEPHROTIC SYNDROME; NEPHROTOXICITY; NOCARDIOSIS; OBSERVATIONAL STUDY; ORBIT CELLULITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELAPSE; REMISSION; TREMOR; TUBERCULOUS OSTEOMYELITIS; UNSPECIFIED SIDE EFFECT; ADOLESCENT; BLOOD; CLINICAL TRIAL; COMPLICATION; DRUG EFFECTS; DRUG RESISTANCE; MIDDLE AGED; RECURRENT DISEASE; YOUNG ADULT;

ADOLESCENT; ADULT; CREATININE; DRUG RESISTANCE; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; PREDNISOLONE; PROSPECTIVE STUDIES; RECURRENCE; REMISSION INDUCTION; STEROIDS; TACROLIMUS; YOUNG ADULT;

EID: 84921778863     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu097     Document Type: Article

References (22)

1. Korbet SM. Treatment of Primary FSGS in Adults. J Am Soc Nephrol 2012; 23: 1769-1776
2. Cattran DC, Rao P. Long-term outcome in children and adults with classic focal segmental glomerulosclerosis. Am J Kidney Dis 1998; 32: 72-79
3. Agarwal SK, Dash SC, Tiwari SC et al. Idiopathic adult focal segmental glomerulosclerosis: a clinicopathological study and response to steroid. Nephron 1993; 63: 168-171
4. Ponticelli C, Villa M, Banfi G et al. Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis? Am J Kidney Dis 1999; 34: 618-625
5. Ittel TH, Clasen W, Fuhs M et al. Long-term ciclosporine A treatment in adults with minimal change nephrotic syndrome or focal segmental glomerulosclerosis. Clin Nephrol 1995; 44: 156-162
6. Li X, Li H, Ye H et al. Tacrolimus therapy in adults with steroid-and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR. Am J Kidney Dis 2009; 54: 51-58
7. Gargah TT, Lakhoua MR. Mycophenolate mofetil in treatment of childhood steroid-resistant nephrotic syndrome. J Nephrol 2011; 24: 203-207
8. KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney Int Suppl 2012; 2: 181-185
9. Ponticelli C, Rizzoni G, Edefonti A et al. A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome. Kidney Int 1993; 43: 1377-1384
10. Cattran DC, Appel GB, Hebert LA et al. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group. Kidney Int 1999; 56: 2220-2226
11. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2014; 37 (Suppl 1): S81-S90
12. Meyrier A, Noel LH, Auriche P et al. Long-term renal tolerance of cyclosporine A treatment in adult idiopathic nephrotic syndrome. Collaborative Group of the Société de Néphrologie. Kidney Int 1994; 45: 1446-1456
13. Heering P, Braun N, Müllejans R et al. Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis. Am J Kidney Dis 2004; 43: 10-18
14. Gipson DS, Trachtman H, Kaskel FJ et al. Clinical trial of focal segmental glomerulosclerosis in children and young adults. Kidney Int 2011; 80: 868-878
15. Hogg RJ, Friedman A, Greene T et al. Renal function and proteinuria after successful immunosuppressive therapies in patients with FSGS. Clin J Am Soc Nephrol 2013; 8: 211-218
16. Braun N, Schmutzler F, Lange C et al. Immunosuppressive treatment for focal segmental glomerulosclerosis in adults. Cochrane Database Syst Rev 2008; 3: CD003233
17. Segarra A, Vila J, Pou L et al. Combined therapy of Tacrolimus and corticosteroids in cyclosporin-resistant or-dependent idiopathic focal glomerulosclerosis: a preliminary uncontrolled study with prospective follow-up. Nephrol Dial Transpl 2002; 17: 655-662
18. Duncan N, Dhaygude A, Owen J et al. Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy. Nephrol Dial Transpl 2004; 19: 3062-3067
19. Choudhry S, Bagga A, Hari P et al. Efficacy and safety of tacrolimus versus cyclosporine in childrenWith steroid-resistant nephrotic syndrome: a randomized controlled trial. Am J Kidney Dis 2009; 53: 760-769
20. Stokes MB, Valeri AM, Markowitz GS et al. Cellular focal segmental glomerulosclerosis: Clinical and pathologic features. Kidney Int 2006; 70: 1783-1792
21. Nankivell BJ, Borrows RJ, Fung CL et al. The natural history of chronic allograft nephropathy. N Engl J Med 2003; 349: 2326-2333
22. Mohan V. Why are Indians more prone to diabetes? J Assoc Physicians India 2004; 52: 468-474